Lactylation Enhances the Activity of Lactate Dehydrogenase A and Promotes the Chemoresistance to Cisplatin Through Facilitating DNA Nonhomologous End Junction in Lung Adenocarcinoma

Ähnliche Einträge

• Phosphorylated SHMT2 Regulates Oncogenesis Through m6A Modification in Lung Adenocarcinoma
  von: Tianyu Han, et al.
  Veröffentlicht: (2024)
• Lactate Dehydrogenase A and a Novel Four‐Gene Signature as Dual Diagnostic Markers for Lung Adenocarcinoma and Ischemic Stroke
  von: Jin Xie, et al.
  Veröffentlicht: (2026)
• NDRG1‐Driven Lactate Accumulation Promotes Lung Adenocarcinoma Progression Through the Induction of an Immunosuppressive Microenvironment
  von: Gujie Wu, et al.
  Veröffentlicht: (2025)
• m6A‐Modified SNRPA Controls Alternative Splicing of ERCC1 Exon 8 to Induce Cisplatin Resistance in Lung Adenocarcinoma
  von: Weina Fan, et al.
  Veröffentlicht: (2024)
• Lactate Metabolism and Lactylation Modification: New Opportunities and Challenges in Cardiovascular Disease
  von: Mengyang Song, et al.
  Veröffentlicht: (2025)